| Primary |
| Sudden Hearing Loss |
14.1% |
| Hypertension |
13.1% |
| Drug Use For Unknown Indication |
10.1% |
| Product Used For Unknown Indication |
7.1% |
| Asthma |
6.1% |
| Tinnitus |
6.1% |
| Headache |
5.1% |
| Suicide Attempt |
5.1% |
| Thrombosis Prophylaxis |
5.1% |
| Atrial Fibrillation |
3.0% |
| Cardiac Failure |
3.0% |
| Encephalopathy |
3.0% |
| Hypercholesterolaemia |
3.0% |
| Retinal Artery Occlusion |
3.0% |
| Venous Insufficiency |
3.0% |
| Angiopathy |
2.0% |
| Constipation |
2.0% |
| Convulsion Prophylaxis |
2.0% |
| Depression |
2.0% |
| Diabetic Retinopathy |
2.0% |
|
| Tachycardia |
7.5% |
| Transaminases Increased |
7.5% |
| Visual Impairment |
7.5% |
| Vomiting |
7.5% |
| Nausea |
5.7% |
| Off Label Use |
5.7% |
| Pemphigoid |
5.7% |
| Priapism |
5.7% |
| Red Blood Cell Count Decreased |
5.7% |
| Cerebral Haemorrhage |
3.8% |
| Epilepsy |
3.8% |
| Gastrointestinal Haemorrhage |
3.8% |
| Gingival Oedema |
3.8% |
| Intentional Overdose |
3.8% |
| Intermittent Claudication |
3.8% |
| International Normalised Ratio Increased |
3.8% |
| Oedema Peripheral |
3.8% |
| Restlessness |
3.8% |
| Road Traffic Accident |
3.8% |
| Tremor |
3.8% |
|
| Secondary |
| Asthma |
11.3% |
| Hypertension |
11.3% |
| Product Used For Unknown Indication |
11.3% |
| Connective Tissue Disorder |
7.5% |
| Cardiovascular Event Prophylaxis |
5.3% |
| Drug Use For Unknown Indication |
5.3% |
| Prophylaxis |
5.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
5.3% |
| Diabetic Retinopathy |
4.5% |
| Headache |
4.5% |
| Analgesic Therapy |
3.8% |
| Chronic Obstructive Pulmonary Disease |
3.8% |
| Hepatitis B |
3.8% |
| Atrial Fibrillation |
3.0% |
| Cardiac Failure |
3.0% |
| Diabetes Mellitus |
3.0% |
| Peripheral Vascular Disorder |
3.0% |
| Retinal Artery Occlusion |
2.3% |
| Atrial Flutter |
1.5% |
| Constipation |
1.5% |
|
| Off Label Use |
20.9% |
| Visual Impairment |
18.6% |
| Hypotension |
7.0% |
| Asthenia |
4.7% |
| Dizziness |
4.7% |
| Melaena |
4.7% |
| Tachycardia |
4.7% |
| Therapeutic Response Unexpected With Drug Substitution |
4.7% |
| Vomiting |
4.7% |
| Arterial Therapeutic Procedure |
2.3% |
| Bradyphrenia |
2.3% |
| Cerebral Haemorrhage |
2.3% |
| Cerebrovascular Accident |
2.3% |
| Drug Hypersensitivity |
2.3% |
| Epilepsy |
2.3% |
| Hypoglycaemia |
2.3% |
| Ill-defined Disorder |
2.3% |
| Lung Infection |
2.3% |
| Medication Error |
2.3% |
| Stevens-johnson Syndrome |
2.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
23.4% |
| Product Used For Unknown Indication |
17.2% |
| Diabetes Mellitus |
8.1% |
| Hypertension |
7.9% |
| Nuclear Magnetic Resonance Imaging |
5.2% |
| Non-small Cell Lung Cancer |
4.2% |
| Depression |
3.5% |
| Chronic Obstructive Pulmonary Disease |
3.3% |
| Vestibular Neuronitis |
3.2% |
| Rheumatoid Arthritis |
3.1% |
| Pain |
2.9% |
| Type 2 Diabetes Mellitus |
2.7% |
| Myocardial Ischaemia |
2.4% |
| Osteoporosis |
2.4% |
| Pulmonary Arterial Hypertension |
2.2% |
| Hypotension |
1.7% |
| Peripheral Vascular Disorder |
1.7% |
| Prophylaxis |
1.6% |
| Arthritis |
1.6% |
| Blood Cholesterol Increased |
1.6% |
|
| Vomiting |
9.6% |
| Thrombocytopenia |
9.1% |
| Weight Decreased |
8.6% |
| Renal Failure |
5.6% |
| Myocardial Infarction |
5.1% |
| Skin Tightness |
5.1% |
| Nausea |
4.6% |
| Nephrogenic Systemic Fibrosis |
4.6% |
| Pneumonia |
4.6% |
| Vision Blurred |
4.6% |
| Cerebrovascular Accident |
4.1% |
| Dyspnoea |
4.1% |
| Fatigue |
4.1% |
| Respiratory Failure |
4.1% |
| Rhabdomyolysis |
4.1% |
| Sepsis |
4.1% |
| Anaemia |
3.6% |
| Brain Oedema |
3.6% |
| Death |
3.6% |
| Pyrexia |
3.6% |
|
